ClinicalTrials.gov
public full text
Public Domain
Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.
Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels#871922
- Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient#846726
- Smartphone-connected, battery-free aptamer-based digital test for quantification of procalcitonin and monitoring of infection at the point of care#475743
- Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients#1008294
- Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis#121381
Record · ID 880591
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive